Autoreactive Diabetogenic T-Cells in NOD Mice Can Efficiently Expand from a Greatly Reduced Precursor Pool

David V. Serreze, Ellis A. Johnson, Harold D. Chapman, Robert T. Graser, Michele P. Marron, Teresa P. DiLorenzo, Pablo Silveira, Yoshitaka Yoshimura, Stanley G. Nathenson, Sebastian Joyce

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

A broad repertoire of pancreatic β-cell autoreactive T-cells normally contributes to the development of type 1 diabetes in NOD mice. However, it has been unknown if a large reduction in the precursor pool from which autoreactive T-cells are drawn would inhibit the development of type 1 diabetes. To address this issue, we reduced the precursor frequency of autoreactive T-cells in NOD mice through allelic exclusion induced by transgenic expression of an H2-Db class I-restricted T-cell receptor (TCR) specific for a pathologically irrelevant lymphocytic choriomeningitis virus (LCMV) peptide. TCR allelic exclusion greatly reduced the pool of T-cells from which diabetogenic effectors could be derived in these NOD.LCMV TCR Tg mice. Surprisingly, this did not impair their type 1 diabetes susceptibility. Furthermore, a diabetogenic CD8 T-cell population that is prevalent in standard NOD mice was present at essentially equivalent levels in pancreatic islets of NOD.LCMV TCR Tg mice. Other data indicated that the antigenic specificity of these CD8 T-cells is primarily the function of a shared TCR-α chain. Although the percentage of TCR transgenic T-cells decreased in NOD versus B6,D2 control mice, much higher total numbers of both the TCR transgenic and the nontransgenic T-cells accumulated in the NOD strain. This transgenic T-cell accumulation in the absence of the cognate peptide indicated that the NOD genetic background preferentially promotes a highly efficient antigen-independent T-cell expansion. This might allow diabetogenic T-cells in NOD mice to undergo an efficient expansion before encountering antigen, which would represent an important and previously unconsidered aspect of pathogenesis.

Original languageEnglish (US)
Pages (from-to)1992-2000
Number of pages9
JournalDiabetes
Volume50
Issue number9
StatePublished - Sep 2001

Fingerprint

Inbred NOD Mouse
T-Lymphocytes
T-Cell Antigen Receptor
Lymphocytic choriomeningitis virus
Type 1 Diabetes Mellitus
Antigens
Peptides
Islets of Langerhans
Epitopes

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

Serreze, D. V., Johnson, E. A., Chapman, H. D., Graser, R. T., Marron, M. P., DiLorenzo, T. P., ... Joyce, S. (2001). Autoreactive Diabetogenic T-Cells in NOD Mice Can Efficiently Expand from a Greatly Reduced Precursor Pool. Diabetes, 50(9), 1992-2000.

Autoreactive Diabetogenic T-Cells in NOD Mice Can Efficiently Expand from a Greatly Reduced Precursor Pool. / Serreze, David V.; Johnson, Ellis A.; Chapman, Harold D.; Graser, Robert T.; Marron, Michele P.; DiLorenzo, Teresa P.; Silveira, Pablo; Yoshimura, Yoshitaka; Nathenson, Stanley G.; Joyce, Sebastian.

In: Diabetes, Vol. 50, No. 9, 09.2001, p. 1992-2000.

Research output: Contribution to journalArticle

Serreze, DV, Johnson, EA, Chapman, HD, Graser, RT, Marron, MP, DiLorenzo, TP, Silveira, P, Yoshimura, Y, Nathenson, SG & Joyce, S 2001, 'Autoreactive Diabetogenic T-Cells in NOD Mice Can Efficiently Expand from a Greatly Reduced Precursor Pool', Diabetes, vol. 50, no. 9, pp. 1992-2000.
Serreze DV, Johnson EA, Chapman HD, Graser RT, Marron MP, DiLorenzo TP et al. Autoreactive Diabetogenic T-Cells in NOD Mice Can Efficiently Expand from a Greatly Reduced Precursor Pool. Diabetes. 2001 Sep;50(9):1992-2000.
Serreze, David V. ; Johnson, Ellis A. ; Chapman, Harold D. ; Graser, Robert T. ; Marron, Michele P. ; DiLorenzo, Teresa P. ; Silveira, Pablo ; Yoshimura, Yoshitaka ; Nathenson, Stanley G. ; Joyce, Sebastian. / Autoreactive Diabetogenic T-Cells in NOD Mice Can Efficiently Expand from a Greatly Reduced Precursor Pool. In: Diabetes. 2001 ; Vol. 50, No. 9. pp. 1992-2000.
@article{05d557f4fbf64785bb937c1fbf4f7e91,
title = "Autoreactive Diabetogenic T-Cells in NOD Mice Can Efficiently Expand from a Greatly Reduced Precursor Pool",
abstract = "A broad repertoire of pancreatic β-cell autoreactive T-cells normally contributes to the development of type 1 diabetes in NOD mice. However, it has been unknown if a large reduction in the precursor pool from which autoreactive T-cells are drawn would inhibit the development of type 1 diabetes. To address this issue, we reduced the precursor frequency of autoreactive T-cells in NOD mice through allelic exclusion induced by transgenic expression of an H2-Db class I-restricted T-cell receptor (TCR) specific for a pathologically irrelevant lymphocytic choriomeningitis virus (LCMV) peptide. TCR allelic exclusion greatly reduced the pool of T-cells from which diabetogenic effectors could be derived in these NOD.LCMV TCR Tg mice. Surprisingly, this did not impair their type 1 diabetes susceptibility. Furthermore, a diabetogenic CD8 T-cell population that is prevalent in standard NOD mice was present at essentially equivalent levels in pancreatic islets of NOD.LCMV TCR Tg mice. Other data indicated that the antigenic specificity of these CD8 T-cells is primarily the function of a shared TCR-α chain. Although the percentage of TCR transgenic T-cells decreased in NOD versus B6,D2 control mice, much higher total numbers of both the TCR transgenic and the nontransgenic T-cells accumulated in the NOD strain. This transgenic T-cell accumulation in the absence of the cognate peptide indicated that the NOD genetic background preferentially promotes a highly efficient antigen-independent T-cell expansion. This might allow diabetogenic T-cells in NOD mice to undergo an efficient expansion before encountering antigen, which would represent an important and previously unconsidered aspect of pathogenesis.",
author = "Serreze, {David V.} and Johnson, {Ellis A.} and Chapman, {Harold D.} and Graser, {Robert T.} and Marron, {Michele P.} and DiLorenzo, {Teresa P.} and Pablo Silveira and Yoshitaka Yoshimura and Nathenson, {Stanley G.} and Sebastian Joyce",
year = "2001",
month = "9",
language = "English (US)",
volume = "50",
pages = "1992--2000",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "9",

}

TY - JOUR

T1 - Autoreactive Diabetogenic T-Cells in NOD Mice Can Efficiently Expand from a Greatly Reduced Precursor Pool

AU - Serreze, David V.

AU - Johnson, Ellis A.

AU - Chapman, Harold D.

AU - Graser, Robert T.

AU - Marron, Michele P.

AU - DiLorenzo, Teresa P.

AU - Silveira, Pablo

AU - Yoshimura, Yoshitaka

AU - Nathenson, Stanley G.

AU - Joyce, Sebastian

PY - 2001/9

Y1 - 2001/9

N2 - A broad repertoire of pancreatic β-cell autoreactive T-cells normally contributes to the development of type 1 diabetes in NOD mice. However, it has been unknown if a large reduction in the precursor pool from which autoreactive T-cells are drawn would inhibit the development of type 1 diabetes. To address this issue, we reduced the precursor frequency of autoreactive T-cells in NOD mice through allelic exclusion induced by transgenic expression of an H2-Db class I-restricted T-cell receptor (TCR) specific for a pathologically irrelevant lymphocytic choriomeningitis virus (LCMV) peptide. TCR allelic exclusion greatly reduced the pool of T-cells from which diabetogenic effectors could be derived in these NOD.LCMV TCR Tg mice. Surprisingly, this did not impair their type 1 diabetes susceptibility. Furthermore, a diabetogenic CD8 T-cell population that is prevalent in standard NOD mice was present at essentially equivalent levels in pancreatic islets of NOD.LCMV TCR Tg mice. Other data indicated that the antigenic specificity of these CD8 T-cells is primarily the function of a shared TCR-α chain. Although the percentage of TCR transgenic T-cells decreased in NOD versus B6,D2 control mice, much higher total numbers of both the TCR transgenic and the nontransgenic T-cells accumulated in the NOD strain. This transgenic T-cell accumulation in the absence of the cognate peptide indicated that the NOD genetic background preferentially promotes a highly efficient antigen-independent T-cell expansion. This might allow diabetogenic T-cells in NOD mice to undergo an efficient expansion before encountering antigen, which would represent an important and previously unconsidered aspect of pathogenesis.

AB - A broad repertoire of pancreatic β-cell autoreactive T-cells normally contributes to the development of type 1 diabetes in NOD mice. However, it has been unknown if a large reduction in the precursor pool from which autoreactive T-cells are drawn would inhibit the development of type 1 diabetes. To address this issue, we reduced the precursor frequency of autoreactive T-cells in NOD mice through allelic exclusion induced by transgenic expression of an H2-Db class I-restricted T-cell receptor (TCR) specific for a pathologically irrelevant lymphocytic choriomeningitis virus (LCMV) peptide. TCR allelic exclusion greatly reduced the pool of T-cells from which diabetogenic effectors could be derived in these NOD.LCMV TCR Tg mice. Surprisingly, this did not impair their type 1 diabetes susceptibility. Furthermore, a diabetogenic CD8 T-cell population that is prevalent in standard NOD mice was present at essentially equivalent levels in pancreatic islets of NOD.LCMV TCR Tg mice. Other data indicated that the antigenic specificity of these CD8 T-cells is primarily the function of a shared TCR-α chain. Although the percentage of TCR transgenic T-cells decreased in NOD versus B6,D2 control mice, much higher total numbers of both the TCR transgenic and the nontransgenic T-cells accumulated in the NOD strain. This transgenic T-cell accumulation in the absence of the cognate peptide indicated that the NOD genetic background preferentially promotes a highly efficient antigen-independent T-cell expansion. This might allow diabetogenic T-cells in NOD mice to undergo an efficient expansion before encountering antigen, which would represent an important and previously unconsidered aspect of pathogenesis.

UR - http://www.scopus.com/inward/record.url?scp=0035459382&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035459382&partnerID=8YFLogxK

M3 - Article

C2 - 11522664

AN - SCOPUS:0035459382

VL - 50

SP - 1992

EP - 2000

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 9

ER -